Literature DB >> 19710422

DLC1 activation requires lipid interaction through a polybasic region preceding the RhoGAP domain.

Patrik Erlmann1, Simone Schmid, Florian A Horenkamp, Matthias Geyer, Thomas G Pomorski, Monilola A Olayioye.   

Abstract

Deleted in Liver Cancer 1 (DLC1) is a GTPase-activating protein (GAP) with specificity for RhoA, RhoB, and RhoC that is frequently deleted in various tumor types. By inactivating these small GTPases, DLC1 controls actin cytoskeletal remodeling and biological processes such as cell migration and proliferation. Here we provide evidence that DLC1 binds to phosphatidylinositol-4,5-bisphosphate (PI(4,5)P(2)) through a previously unrecognized polybasic region (PBR) adjacent to its RhoGAP domain. Importantly, PI(4,5)P(2)-containing membranes are shown to stimulate DLC1 GAP activity in vitro. In living cells, a DLC1 mutant lacking an intact PBR inactivated Rho signaling less efficiently and was severely compromised in suppressing cell spreading, directed migration, and proliferation. We therefore propose that PI(4,5)P(2) is an important cofactor in DLC1 regulation in vivo and that the PBR is essential for the cellular functions of the protein.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19710422      PMCID: PMC2762136          DOI: 10.1091/mbc.e09-03-0247

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  48 in total

Review 1.  Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility.

Authors:  Ann P Wheeler; Anne J Ridley
Journal:  Exp Cell Res       Date:  2004-11-15       Impact factor: 3.905

2.  Identification of ARAP3, a novel PI3K effector regulating both Arf and Rho GTPases, by selective capture on phosphoinositide affinity matrices.

Authors:  S Krugmann; K E Anderson; S H Ridley; N Risso; A McGregor; J Coadwell; K Davidson; A Eguinoa; C D Ellson; P Lipp; M Manifava; N Ktistakis; G Painter; J W Thuring; M A Cooper; Z-Y Lim; A B Holmes; S K Dove; R H Michell; A Grewal; A Nazarian; H Erdjument-Bromage; P Tempst; L R Stephens; P T Hawkins
Journal:  Mol Cell       Date:  2002-01       Impact factor: 17.970

3.  Morphological changes and detachment of adherent cells induced by p122, a GTPase-activating protein for Rho.

Authors:  M Sekimata; Y Kabuyama; Y Emori; Y Homma
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

4.  DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1.

Authors:  I O Ng; Z D Liang; L Cao; T K Lee
Journal:  Cancer Res       Date:  2000-12-01       Impact factor: 12.701

5.  DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas.

Authors:  Bao-Zhu Yuan; Amy M Jefferson; Kimberly T Baldwin; Snorri S Thorgeirsson; Nicholas C Popescu; Steven H Reynolds
Journal:  Oncogene       Date:  2004-02-19       Impact factor: 9.867

Review 6.  Regulation and cellular roles of phosphoinositide 5-kinases.

Authors:  Paschal A Oude Weernink; Martina Schmidt; Karl H Jakobs
Journal:  Eur J Pharmacol       Date:  2004-10-01       Impact factor: 4.432

7.  Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities.

Authors:  Xiaolan Qian; Guorong Li; Holly K Asmussen; Laura Asnaghi; William C Vass; Richard Braverman; Kenneth M Yamada; Nicholas C Popescu; Alex G Papageorge; Douglas R Lowy
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-15       Impact factor: 11.205

8.  ASAP1, a phospholipid-dependent arf GTPase-activating protein that associates with and is phosphorylated by Src.

Authors:  M T Brown; J Andrade; H Radhakrishna; J G Donaldson; J A Cooper; P A Randazzo
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

9.  ACAPs are arf6 GTPase-activating proteins that function in the cell periphery.

Authors:  T R Jackson; F D Brown; Z Nie; K Miura; L Foroni; J Sun; V W Hsu; J G Donaldson; P A Randazzo
Journal:  J Cell Biol       Date:  2000-10-30       Impact factor: 10.539

10.  A dual functional signal mediator showing RhoGAP and phospholipase C-delta stimulating activities.

Authors:  Y Homma; Y Emori
Journal:  EMBO J       Date:  1995-01-16       Impact factor: 11.598

View more
  16 in total

1.  Solution structure of the phosphotyrosine binding (PTB) domain of human tensin2 protein in complex with deleted in liver cancer 1 (DLC1) peptide reveals a novel peptide binding mode.

Authors:  Lihong Chen; Changdong Liu; Frankie Chi Fat Ko; Naining Xu; Irene Oi-Lin Ng; Judy Wai Ping Yam; Guang Zhu
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

2.  Deciphering the Molecular and Functional Basis of RHOGAP Family Proteins: A SYSTEMATIC APPROACH TOWARD SELECTIVE INACTIVATION OF RHO FAMILY PROTEINS.

Authors:  Ehsan Amin; Mamta Jaiswal; Urszula Derewenda; Katarina Reis; Kazem Nouri; Katja T Koessmeier; Pontus Aspenström; Avril V Somlyo; Radovan Dvorsky; Mohammad R Ahmadian
Journal:  J Biol Chem       Date:  2016-08-01       Impact factor: 5.157

3.  Functional cross-talk between ras and rho pathways: a Ras-specific GTPase-activating protein (p120RasGAP) competitively inhibits the RhoGAP activity of deleted in liver cancer (DLC) tumor suppressor by masking the catalytic arginine finger.

Authors:  Mamta Jaiswal; Radovan Dvorsky; Ehsan Amin; Sarah L Risse; Eyad K Fansa; Si-Cai Zhang; Mohamed S Taha; Aziz R Gauhar; Saeideh Nakhaei-Rad; Claus Kordes; Katja T Koessmeier; Ion C Cirstea; Monilola A Olayioye; Dieter Häussinger; Mohammad R Ahmadian
Journal:  J Biol Chem       Date:  2014-01-17       Impact factor: 5.157

Review 4.  Latest developments in experimental and computational approaches to characterize protein-lipid interactions.

Authors:  Hyunju Cho; Ming Wu; Betul Bilgin; S Patrick Walton; Christina Chan
Journal:  Proteomics       Date:  2012-11       Impact factor: 3.984

5.  A stretch of polybasic residues mediates Cdc42 GTPase-activating protein (CdGAP) binding to phosphatidylinositol 3,4,5-trisphosphate and regulates its GAP activity.

Authors:  Fereshteh Karimzadeh; Martin Primeau; Driss Mountassif; Isabelle Rouiller; Nathalie Lamarche-Vane
Journal:  J Biol Chem       Date:  2012-04-19       Impact factor: 5.157

6.  The 5-phosphatase OCRL mediates retrograde transport of the mannose 6-phosphate receptor by regulating a Rac1-cofilin signalling module.

Authors:  Vanessa A van Rahden; Kristina Brand; Juliane Najm; Joerg Heeren; Suzanne R Pfeffer; Thomas Braulke; Kerstin Kutsche
Journal:  Hum Mol Genet       Date:  2012-08-19       Impact factor: 6.150

7.  A WXW motif is required for the anticancer activity of the TAT-RasGAP317-326 peptide.

Authors:  David Barras; Nadja Chevalier; Vincent Zoete; Rosemary Dempsey; Karine Lapouge; Monilola A Olayioye; Olivier Michielin; Christian Widmann
Journal:  J Biol Chem       Date:  2014-07-09       Impact factor: 5.157

8.  PKA-induced dimerization of the RhoGAP DLC1 promotes its inhibition of tumorigenesis and metastasis.

Authors:  Frankie Chi Fat Ko; Lo-Kong Chan; Karen Man-Fong Sze; Yin-Shan Yeung; Edith Yuk-Ting Tse; Ping Lu; Ming-Hua Yu; Irene Oi-Lin Ng; Judy Wai Ping Yam
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 9.  RLIP76: A Structural and Functional Triumvirate.

Authors:  Jasmine Cornish; Darerca Owen; Helen R Mott
Journal:  Cancers (Basel)       Date:  2021-05-04       Impact factor: 6.639

10.  The RhoGAP protein Deleted in Liver Cancer 3 (DLC3) is essential for adherens junctions integrity.

Authors:  G Holeiter; A Bischoff; A C Braun; B Huck; P Erlmann; S Schmid; R Herr; T Brummer; M A Olayioye
Journal:  Oncogenesis       Date:  2012-06-04       Impact factor: 7.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.